Benzinga | Aug 4, 2021 12:13PM EDT

Canaccord Genuity Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $185

Canaccord Genuity analyst Kyle Rose maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $190 to $185.